Clin Oral Invest (2017) 21:2379–2388 DOI 10.1007/s00784-016-2033-7 ORIGINAL ARTICLE Effects of enamel matrix derivative on non-surgical management of peri-implant mucositis: a double-blind randomized clinical trial 1 1,2,3 1 1,4 Atabak Kashefimehr & Reza Pourabbas & Masumeh Faramarzi & Ali Zarandi & 1 2,3 2,3,5 Abouzar Moradi & Howard C. Tenenbaum & Amir Azarpazhooh Received: 2 March 2016 /Accepted: 8 December 2016 /Published online: 30 December 2016 Springer-Verlag Berlin Heidelberg 2016 Abstract The levels of IL-6 and IL-17 cytokines in PICF were evaluat- Background Peri-implant diseases have been recognized as ed by enzyme-linked immunosorbent (ELISA). being among the ever-increasing complications related to den- Results Three-month post-interventional assay revealed sig- tal implants. The aim of this study was to evaluate the adjunc- nificant improvements in BOP and PD in the test group in tive use of enamel matrix derivative (EMD) to mechanical comparison to the control group (P < 0.0001). Relative to debridement (MD) in patients with these conditions in terms control, IL-6 and IL-17 levels were reduced significantly of clinical parameters and cytokine levels of peri-implant cre- (p < 0.05) in the test group compared to the control group. vicular fluid (PICF). Conclusion Application of EMD can be considered an
Clinical Oral Investigations – Springer Journals
Published: Dec 30, 2016
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera